WUHAN, China, March 26, 2021 /PRNewswire/ — Chime Biologics, a China-based, world-class CDMO firm, introduced as we speak that it has secured a complete dedication of US$190 million funding from institutional traders, and over $100 million funding has already been closed as we speak. This spherical of financing was led by VMS Group, adopted by Constancy Worldwide and Panacea Enterprise. Beforehand Chime Biologics had simply accomplished its Collection A spherical financing of US$125 million in early 2020.
Chime Biologics has constructed the world’s first GE KuBio modular bio-manufacturing facility in Wuhan Bio-Lake Biotech Trade Improvement Zone of China (China Optics Valley). The ability complies with world high quality requirements of ICH, FDA, EMA and NMPA. With its state-of-the-art facility and wealthy expertise in bio-manufacturing, Chime Biologics supplies one-stop built-in options to help the dynamic wants of the quickly evolving bio-pharmaceutical business from early drug improvement to late stage medical and business cGMP manufacturing. Since 2016 Chime Biologics has been sustaining a hit price of 100% in bio-manufacturing and offering varied prospects with top-quality biopharmaceutical merchandise.
With a purpose to meet the growing calls for for CDMO providers from varied prospects, Chime Biologics has already began the second part of its facility enlargement to extend the whole manufacturing capability to greater than 140,000L inside the subsequent 5 years.
“The profitable completion of this financing spherical will additional speed up the capability enlargement strategy of Chime Biologics,” stated Mr. James Huang, the Govt Chairman of Chime Biologics. “With the fast progress of China’s biologics market and the surging demand for CDMO service, Chime Biologics will additional leverage on its world-class high quality system and commercial-scale manufacturing capabilities to proceed offering our prospects worldwide with first-class CDMO providers.”
Mr. Andrew Ng, the Managing Director and Head of Healthcare of VMS Group stated, “We’re very impressed by the manufacturing observe document and fast-growing buyer base of Chime Biologics. With our funding and strategic help，we strongly consider Chime Biologics might broaden its manufacturing and enterprise quickly, and turn out to be one of many main CDMO gamers each in China and the worldwide enviornment within the close to future.”
“It’s the nice honor of Chime Biologics to have the belief and recognition from internationally famend institutional traders. We are going to constantly construct up superior know-how platforms and extra capacities to higher serve our prospects, and in addition welcome biologics companions from all around the world to return right here, exchanging experiences and looking for for developments collectively,” stated Dr. John (Xianfang) Zeng, CEO of Chime Biologics Restricted.
About Chime Biologics
Chime Biologics is a world-class CDMO with operations in China that gives customer-centric and cost-effective outsourcing providers for biopharmaceutical improvement and manufacturing. Its world’s first GE KuBio facility is positioned at Wuhan’s Bio-Lake biotech business improvement zone of China, with clear path to broaden the whole capability as much as 140,000+ liters within the close to future. Chime Biologics is ISO 14001:2015 and ISO 45001:2018 licensed, and is dedicated to uphold the best diploma of integrity. Since 2016 Chime Biologics has been offering prospects with medical supplies for pre-clinical and medical levels globally and supporting their manufacturing at varied scales from 50L, 200L, 500L to 2,000L throughout IND-enabling research to late-stage course of improvement, scale-up, course of characterization and course of efficiency qualification. Since then, Chime Biologics has been offering medical provide to over 20 nations worldwide.
About VMS Group
VMS Group is a number one multi-strategy monetary group, offering asset administration (personal fairness, actual property and structured finance), brokerage and company finance advisory providers. VMS Personal Fairness makes a speciality of progress capital, with a deal with China-related investments in healthcare, know-how, media, telecom (TMT) and shopper sectors. VMS healthcare observe focuses on the following revolutionary firms across the globe that would resolve unmet medical wants throughout medical therapy, analysis and normal well being administration. As of as we speak, VMS Group has efficiently accomplished greater than 100 investments each onshore in China and offshore around the globe since inception, and at the moment manages complete belongings in extra of USD 3.eight billion .
About Constancy Worldwide
Constancy Worldwide gives funding options and providers and retirement experience to greater than 2.5 million prospects globally. As a privately held, purpose-driven firm with a 50-year heritage, we predict generationally and make investments for the long run. Working in additional than 25 nations and with $706.Three billion in complete belongings, our shoppers vary from central banks, sovereign wealth funds, giant corporates, monetary establishments, insurers and wealth managers, to non-public people.
About Panacea Enterprise
Panacea Enterprise is a science-focused enterprise capital agency specializing in investing in and incubating early stage life science firms with disruptive and breakthrough applied sciences and discoveries that may doubtlessly deal with big unmet medical wants and improve high quality of life. Our funding is targeted and exact.We take very hands-on strategy to our portfolio firms, usually performing as members of the founding staff. Additionally we usher in important expertise, experience, useful resource, and community. Panacea Enterprise manages each USD fund and RMB fund, and has an operation workplace in Shanghai, China. Our funding groups are positioned in Europe, US and China masking most main life science hubs.
Cellphone: +86-027 8787 9208
Electronic mail: firstname.lastname@example.org
SOURCE Chime Biologics